Write a short review & help students like you! Over 1,500 students already shared their experience.
| Application Deadline: | Up to the start of the course (subject to availability) | ||
| Location: | London / United Kingdom / View location on map ▾ Hide location on map ▴ | ||
| Duration: | 12 months | Start Date: | September |
| Educational Form: |
| ||
| Education Variants: |
| ||
| Languages: | English | ||
One year full-time, two years part-time/distance learning
The MSc in Cancer Therapeutics is run by the Barts Cancer Institute, one of the top cancer research institutes in the country (2008 RAE) and a Cancer Research UK Centre of Excellence.
This MSc course aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of cancer therapeutics and the development, evaluation and implementation of new treatments. This is underpinned by a thorough knowledge of cancer biology and pathology, research methodologies, drug development and regulatory issues. There is an emphasis on practical skills during the research skills module and the three month laboratory project undertaken during semester three.
You will be taught by scientists and clinicians who are experts in the field, and have the opportunity to work amongst leading research groups during the laboratory project.
On completion of the programme you will:
• Have a thorough knowledge of the principles underlying cancer treatment
• Be able to demonstrate skills in gathering, recording, analysing and presenting information
• Understand the regulatory framework underlying clinical research
• Understand the principles of laboratory methodologies applied to clinical trials
• Understand the steps involved in developing and implementing new treatments
• Be able to apply this knowledge in their own professional roles
• Be able to contribute to the research activity and knowledge base in improving cancer care.
Programme outline
Core modules:
• Research Skills and Sciences
• Cancer Biology
• Cancer Pharmacology
• Site Specific Tumour Treatment
• Ablative Therapy
• Biological Therapies
• Drug Development
• Lab Project
Optional modules:
• Imaging
• Pathology of Cancer
• Genomic Approaches to Human Diseases
• Paediatric and Adolescent Oncology
• Cancer Prevention and Screening
Assessment
Assessment will be based on written assignments, presentations, continuous assessments, written or MCQ examinations, and a full lab-project write-up.
Admissions:
The programme is open to graduate scientists, nurses, clinicians and other medical professionals working in healthcare, the pharmaceutical industry or contract research organisations. Entry to the programme will require a degree, or degree equivalent qualification, from a recognised academic institution or an appropriate professional qualification or experience.
Location:
The Barts Cancer Institute is based on the beautiful Charterhouse Square Campus, in the heart of the City of London.
Our Teaching Centre along with our research laboratories and clinical trials centre are located primarily on this campus, within minutes of the new Barts Cancer Centre, one of the most advanced cancer centres in Europe.
Charterhouse Square is 1 of 3 Queen Mary University of London campuses, all based in the East End of London. Rich in history and diversity, it is in one of the most vibrant and exciting areas of London.
For further information about the course, the Barts Cancer Institute and what it’s like to study with us, please visit our website:
General enquiries:
Barts Cancer institute
Teaching Centre Tel: +44(0)20 7882 2081
email: cancercourses@qmcr.qmul.ac.uk
For informal academic enquiries, please contact
Dr Simon Joel
MSc Cancer Therapeutics Course Director:
email: s.p.joel@qmul.ac.uk
The Barts Cancer Institute is part of Barts and The London School of Medicine and Dentistry,
Queen Mary University of London.
Core modules:
• Research Skills and Sciences
• Cancer Biology
• Cancer Pharmacology
• Site Specific Tumour Treatment
• Ablative Therapy
• Biological Therapies
• Drug Development
• Lab Project
Optional modules:
• Imaging
• Pathology of Cancer
• Genomic Approaches to Human Diseases
• Paediatric and Adolescent Oncology
• Cancer Prevention and Screening
Distance learning optionThis programme is now also available as a distance learning option, based on WebCT. Students are able to follow each lecture on line via lecture recording and slide/whiteboard content. All assigned work is submitted via WebCT. Students are encouraged to interact with teaching staff and other students online discussion forums and joint or group activities and also attend a Summer school.
You are normally required to take an English Proficiency Test.
Most European Universities recognise the IELTS test.
Take testThe programme is open to graduate scientists, nurses, clinicians and other medical professionals working in healthcare, the pharmaceutical industry or contract research organisations.
Entry to the programme will require a degree, or degree equivalent qualification, from a recognised academic institution or an appropriate professional qualification or experience.
| IELTS Band: | 7.0 |
| Cambridge English: Advanced (CAE): | Grade B (Score: 75) |
| TOEFL Paper-based: | 610 |
| TOEFL Internet-based: | 100 |
You can contact Dr Simon Joel to ask a question about Cancer Therapeutics at Queen Mary, University of London.
Using the form on this page, you can directly ask questions to the contactpersons at the university.
Fill out your contact information and message. The information you fill out in this form will be sent directly to the university. They will reply to you on the e-mail address you provide here.
Explain your academic background in the message; the more sophisticated your e-mail, the better the answer.
MastersPortal.eu cannot take any responsibility for the answering of contacts or for the content of their replies.